AESTHETIC MED INTL HLDG GR L PAIYY
ADS · ADR · CUSIP 00809M104
- SectorHealth care
- IndustryServices-Specialty Outpatient Facilities, NEC
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.45.
Trends to Q2 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 6 |
| Q4 2022 | 6 |
| Q1 2023 | 6 |
| Q2 2023 | 6 |
| Q3 2023 | 7 |
| Q4 2023 | 7 |
| Q1 2024 | 6 |
| Q2 2024 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 1 | 1 |
| Q1 2023 | 1 | 2 |
| Q2 2023 | 1 | 2 |
| Q3 2023 | 2 | 0 |
| Q4 2023 | 3 | 1 |
| Q1 2024 | 2 | 2 |
| Q2 2024 | 0 | 5 |
Biggest buyers
| None |
Biggest sellers
| IDG Technology Venture Investment IV, LLC | Sold out | -396.1k |
| RENAISSANCE TECHNOLOGIES LLC | Sold out | -14.7k |
| CITADEL ADVISORS LLC | Sold out | -11.4k |
| Nordwand Advisors, LLC | Sold out | -2.0k |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Sold out | 0 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Hainan Oriental Jiechuang Investment Partnership (Limited Pa
13D · may seek influence
filed 2026-04-03
Stated purposeOn July 20, 2022, certain parties entered into the respective agreements as below: (i) the Issuer, Dr. Zhou Pengwu, Ms. Ding Wenting (together with Dr. Zhou Pengwu, the "Founders") and Jiechuang entered into a Share Subscription Agreement (the "Jiechuang Agreement") whereby Jiechuang or its designated entity agrees to subscribe 36,402,570 newly issued ordinary shares of the Issuer for the equivalent US dollars of RMB170,000,000; (ii) the Issuer, Seefar Global Holdings Limited ("Seefar"), Jubilee Set Investments Limited ("Jubilee"), Pengai Hospital Management Corporation ("PH Management", together with Seefar and Jubilee, the "Sellers"), the Founders and Wanda entered into a Share Purchase Agreement (the "Wanda Agreement") whereby Wanda agrees to purchase 21,321,962 shares of ordinary sha… Full filing |
37.6% |
Insider purchases and sales in Q2 2024
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2024.
Holders, Q2 2024
| Manager | Shares | Change |
|---|---|---|
| RHUMBLINE ADVISERS 0.00% of their portfolio | 20.1k $9.0k | Unchanged |